Kelyniam Global Acquires MED-ALLY
Business Wire - Wed Nov 19, 7:00AM CST
Kelyniam Global, Inc. (OTC Pink: KLYG), an innovative medical device design and manufacturing company, announced today it has acquired MED-ALLY, LLC as part of its product diversification initiative. MED-ALLY applies custom, proprietary Neuromodulation technology to create a number of external and implantable medical devices that can be used to treat a wide array of conditions including chronic pain management, urinary incontinence, sleep apnea, Tinnitus and Deep Brain Stimulation applications such as Alzheimer's, Epilepsy, and Parkinson's disease.